Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2016 | Research article

Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats

Authors: Muhammad Taher, Tg Muhamad Faris Syafiq Tg Zakaria, Deny Susanti, Zainul Amiruddin Zakaria

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Abstract

Background

Various parts of Garcinia mangostana Linn., including its pericarp, have been traditionally used to treat a variety of ailments. In an attempt to establish its medicinal value, the present study was carried out to determine the hypoglycaemic potential of G. mangostana pericarp ethanolic extract (GME) using the streptozotocin-induced (STZ) diabetic rats.

Methods

GME at 2,000 mg/kg was subjected to a single-dose acute toxicity test. Following this, the effect of GME (50, 100, and 200 mg/kg) on blood glucose level of normoglycaemic and STZ-induced diabetic rats was determined using single-dose (acute) and multiple-dose (subacute) approaches. Subsequent to the multiple-dose study, serum biochemical analysis and liver histopathological examination were also performed. Throughout the experiments, the effect of GME was compared against the standard hypoglycaemic drug, glibenclamide.

Results

GME was safe for oral consumption up to the dose of 2,000 mg/kg. In both single- and multiple-dose studies, GME significantly (p < 0.05) reduced the blood glucose level in normoglycaemic rats and STZ-induced diabetic rats when compared against the normal control group or diabetic control group, respectively. Moreover, GME also significantly (p < 0.05) increased the rats’ body weight in comparison to the diabetic control group in the multiple-dose study. GME also significantly (p < 0.05) reduced the levels of certain biochemical parameters [i.e., triglycerides (TG), total cholesterol (TC), low density lipoprotein (LDL), very low density lipoprotein (VLDL), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), urea, and creatinine] while increased the others [i.e., high density lipoprotein (HDL) and total protein (TP)] when compared to the diabetic control group. Histopathological assessment of the collected liver revealed a mild increase in the population of β-cells in the diabetic rats.

Conclusion

GME exerts the hypoglycaemic activity possibly by increasing the population of insulin-producing β-cells. This activity could be attributed to the presence of antioxidant-bearing tannins like epicathecin, and xanthones like α-mangostin. Thus, the findings demonstrated that GME could be a potential candidate in the management of diabetes owing to its hypoglycaemic effect.

Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta: U.S. Department of Health and Human Services; 2014.

International Diabetes Federation: Diabetes Malaysia. http://www.idf.org/membership/wp/malaysia. Accessed 7 Mar 2016.

Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Rad Biol Med. 2011;50:567–75.CrossRefPubMedPubMedCentral

Mahabusarakam W, Wiriyachitra P, Taylor WC. Chemical constituents of Garcinia mangostana. J Nat Prod. 1987;50:474–8.CrossRef

Balasubramanian K, Rajagopalan K. Novel xanthones from Garcinia mangostana, structures of BR-xanthone-A and BR-xanthone-B. Phytochemistry. 1988;27:1552–4.CrossRef

Sen AK, Sarkar KK, Mazumder PC, Banerji N, Uusvuori R, Hase TA. The structures of garcinones a, b and c: Three new xanthones from Garcinia mangostana. Phytochemistry. 1982;21:1747–50.CrossRef

Peres V, Nagem TJ, de Oliveira FF. Tetraoxygenated naturally occurring xanthones. Phytochemistry. 2000;55:683–710.CrossRefPubMed

Pedraza-Chaverri J, Cárdenas-Rodríguez N, Orozco-Ibarra M, Pérez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol. 2008;46:3227–39.CrossRefPubMed

Jung H-A, Su B-N, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem. 2006;54:2077–82.CrossRefPubMed

10.

Doi H, Shibata M-A, Shibata E, Morimoto J, Akao Y, Iinuma M, Tanigawa N, Otsuki Y. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res. 2009;29:2485–95.PubMed

11.

Chen L-G, Yang L-L, Wang C-C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol. 2008;46:688–93.CrossRefPubMed

12.

Cui J, Hu W, Cai Z, Liu Y, Li S, Tao W, Xiang H. New medicinal properties of mangostins: Analgesic activity and pharmacological characterisation of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacol Biochem Behav. 2010;95:166–72.CrossRefPubMed

13.

Chen S-X, Wan M, Loh B-N. Active constituents against HIV-1 protease from Garcinia mangostana. Planta Med. 1996;62:381–2.CrossRefPubMed

14.

Kondo M, Zhang L, Ji H, Kou Y, Ou B. Bioavailability and antioxidant effects of a xanthone-rich Mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem. 2009;57:8788–92.CrossRefPubMed

15.

Kaomongkolgit R, Jamdee K, Chaisomboon N. Antifungal activity of alpha-mangostin against Candida albicans. J Oral Sci. 2009;51:401–6.CrossRefPubMed

16.

Nakatani K, Atsumi M, Arakawa T, Oosawa K, Shimura S, Nakahata N, Ohizumi Y. Inhibitions of histamine release and prostaglandin E 2 synthesis by mangosteen, a Thai medicinal plant. Biol Pharm Bull. 2002;25:1137–41.CrossRefPubMed

17.

Sakagami Y, Iinuma M, Piyasena K, Dharmaratne H. Antibacterial activity of α-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine. 2005;12:203–8.CrossRefPubMed

18.

Suksamrarn S, Suwannapoch N, Phakhodee W, Thanuhiranlert J, Ratananukul P, Chimnoi N, Suksamrarn A. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem Pharm Bull. 2003;51:857–9.CrossRefPubMed

19.

Tang Y-P, Li P-G, Kondo M, Ji H-P, Kou Y, Ou B. Effect of a mangosteen dietary supplement on human immune function: a randomised, double-blind, placebo-controlled trial. J Med Food. 2009;12:755–63.CrossRefPubMed

20.

Ryu HW, Cho JK, Curtis-Long MJ, Yuk HJ, Kim YS, Jung S, Kim YS, Lee BW, Park K. H: α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry. 2011;72:2148–54.CrossRefPubMed

21.

Manaharan T, Palanisamy UD, Ming CH. Tropical plant extracts as potential antihyperglycemic agents. Molecules. 2012;17:5915–23.CrossRefPubMed

22.

Nelli GB, Kilari EK. Antidiabetic effect of α-mangostin and its protective role in sexual dysfunction of streptozotocin induced diabetic male rats. Syst Biol Reprod Med. 2013;59:319–28.CrossRefPubMed

23.

Duckworth WC. Hyperglycemia and cardiovascular disease. Curr Atheros Rep. 2001;3:383–91.CrossRef

24.

Elmalí E, Altan N, Bukan N. Effect of the sulphonylurea glibenclamide on liver and kidney antioxidant enzymes in streptozocin-induced diabetic rats. Drugs R D. 2004;5:203–8.CrossRefPubMed

25.

Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Rad Biol Med. 1996;20:463–6.CrossRefPubMed

26.

Smith PR, Thornalley PJ. Mechanism of the degradation of non‐enzymatically glycated proteins under physiological conditions. Eur J Biochem. 1992;210:729–39.CrossRefPubMed

27.

Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res. 2009;23:1047–65.CrossRefPubMed

28.

Li L, Brunner I, Han AR, Hamburger M, Kinghorn AD, Frye R, Butterweck V. Pharmacokinetics of α‐mangostin in rats after intravenous and oral application. Mol Nutr Food Res. 2011;55:S67–74.CrossRefPubMed

29.

Chin Y-W, Kinghorn AD. Structural characterisation, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini Rev Org Chem. 2008;5:355–64.CrossRefPubMedPubMedCentral

30.

Li L, Han A-R, Kinghorn AD, Frye RF, Derendorf H, Butterweck V. Pharmacokinetic properties of pure xanthones in comparison to a mangosteen fruit extract in rats. Planta Med. 2013;79:646–53.CrossRefPubMed

31.

Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963–72.CrossRefPubMed

32.

Ferreira SB, Sodero AC, Cardoso MF, Lima ES, Kaiser CR, Silva Jr FP, Ferreira VF. Synthesis, biological activity, and molecular modeling studies of 1 h-1, 2, 3-triazole derivatives of carbohydrates as α-glucosidases inhibitors. J Med Chem. 2010;53:2364–75.CrossRefPubMed

33.

Krentz AJ, Bailey CJ. Oral antidiabetic agents: Current Role in Type 2 Diabetes Mellitus. Drug. 2005;65:385–411.CrossRef

34.

Kamalakkannan N, Prince PSM. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin‐induced diabetic wistar rats. Basic Clin Pharmacol Toxicol. 2006;98:97–103.CrossRefPubMed

35.

Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V. Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm. in STZ-induced diabetic rats. Chem-Biol Interact. 2009;182:67–72.CrossRefPubMed

36.

Chivapat S, Wongsinkongman PCP, Rungsipipat CPA. Chronic toxicity study of Garcinia mangostana Linn. pericarp extract. Thai J Vet Med. 2011;41:45–53.

37.

Zhou H-C, Lin Y-M, Wei S-D, Nora Tam T-Y. Structural diversity and antioxidant activity of condensed tannins fractionated from mangosteen pericarp. Food Chem. 2011;129:1710–20.CrossRef

38.

Peaslee MH, Einhellig FA. Tannic acid-induced alterations in mouse growth and pituitary melanocyte-stimulating hormone activity. Toxicol Appl Pharmacol. 1973;25:507–14.CrossRefPubMed

39.

Jambunathan R, Mertz ET. Relation between tannin levels, rat growth, and distribution of proteins in sorghum. J Agric Food Chem. 1973;21:692–6.CrossRefPubMed

40.

Kasetti RB, Rajasekhar MD, Kondeti VK, Fatima SS, Kumar EGT, Swapna S, Ramesh B, Rao CA. Antihyperglycemic and antihyperlipidemic activities of methanol: water (4: 1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats. Food Chem Toxicol. 2010;48:1078–84.CrossRefPubMed

41.

Bai VN. Effect of Gymnema montanum leaves on serum and tissue lipids in alloxan diabetic rats. J Diabetes Res. 2003;4:183–9.

42.

Ohaeri O. Effect of garlic oil on the levels of various enzymes in the serum and tissue of streptozotocin diabetic rats. Biosci Rep. 2001;21:19–24.CrossRefPubMed

43.

Zakaria ZA, Abdul Hisam EE, Rofiee MS, Norhafizah M, Somchit MN, Teh LK, Salleh MZ. In vivo antiulcer activity of the aqueous extract of Bauhinia purpurea leaf. J Ethnopharmacol. 2011;137:1047–54.CrossRefPubMed

44.

Nadkarni KM, Nadkarni AK. Indian Materia Medica - with Ayurvedic, Unani-Tibbi, Siddha, Allopathic, Homeopathic, Naturopathic and Home remedies, vol. 1. Bombay: Popular Prakashan Private Ltd.; 1999.

45.

Yoshimura M, Ninomiya K, Tagashira Y, Maejima K, Yoshida T, Amakura Y. Polyphenolic constituents of the pericarp of mangosteen (Garcinia mangostana L.). J Agric Food Chem. 2015;63:7670–4.CrossRefPubMed

46.

Asai F, Tosa H, Tanaka T, Iinuma M. A xanthone from pericarps of Garcinia mangostana. Phytochem. 1995;39:943–4.CrossRef

47.

Mohamed GA, Ibrahim SR, Shaaban MI, Ross SA. Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia. 2014;98:215–21.CrossRefPubMed

48.

Xu Z, Huang L, Chen X-H, Zhu X-F, Qian X-J, Feng G-K, Lan W-J, Li H-J. Cytotoxic prenylated xanthones from the pericarps of Garcinia mangostana. Molecules. 2014;19:1820–7.CrossRefPubMed

49.

Zhou X, He L, Wu X, Zhong Y, Zhang J, Wang Y, Wang B, Xu Z, Qiu S. Two new xanthones from the pericarp of Garcinia mangostana. Nat Prod Res. 2015;29:19–23.CrossRefPubMed

50.

Xu T, Deng Y, Zhao S, Shao Z. A new xanthone from the pericarp of Garcinia mangostana. J Chem Res. 2016;40:10–1.CrossRef

51.

Kumari M, Jain S. Tannins: An antinutrient with positive effect to manage diabetes. Res J Recent Sci. 2012;1:70–3.

52.

Kim MJ, Ryu GR, Chung JS, Sim SS, Min DS, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas. 2003;26:292–9.CrossRefPubMed

53.

Jariyapongskul A, Areebambud C, Suksamrarn S, Mekseepralard C. Alpha-Mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes rats. BioMed Res Int. 2015;2015:785826. Available at http://dx.doi.org/10.1155/2015/785826.CrossRefPubMedPubMedCentral

54.

Sellamuthu PS, Muniappan BP, Perumal SM, Kandasamy M. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Heatlh Sci. 2009;55:206–14.CrossRef

55.

Miura T, Ichiki H, Hashimoto I, Iwamoto N, Kato M, Kubo M, Ishihara E, Komatsu Y, Okada M, Ishida T, Tanigawa K. Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine. 2001;8:85–7.CrossRefPubMed

56.

Ryu HW, Cho JK, Curtis-Long MJ, Yuk HJ, Kim YS, Jung S, Kim YS, Lee BW, Park KH. α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana. Phytochemistry. 2011;72:2148–54.CrossRefPubMed

Title: Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats
Authors: Muhammad Taher
Tg Muhamad Faris Syafiq Tg Zakaria
Deny Susanti
Zainul Amiruddin Zakaria
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-016-1118-9

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Inhibitory action on the production of advanced glycation end products (AGEs) and suppression of free radicals in vitro by a Sri Lankan polyherbal formulation Nawarathne Kalka

Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2

Effectiveness and safety of ShenXiong glucose injection for acute ischemic stroke: a systematic review and GRADE approach

Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury

Anti-fatigue effect of Amarkand on endurance exercise capacity in rats

Cytotoxicity of methanol extracts of 10 Cameroonian medicinal plants towards multi-factorial drug-resistant cancer cell lines